The present invention relates to drug mixing systems generally and particularly to a vial adapter with improved connection features for connecting thereto a vial.
Drug mixing systems are well known in the art. One particular drug mixing system is described in published PCT patent application WO 2005/041846, assigned to the current assignee of the present application, the disclosure of which is incorporated herein by reference. The drug mixing system is commercially available from Teva Medical Ltd. and is sold under the brand name Tevadaptor. It is a system for safe compounding and administration of hazardous intravenous drugs. Tevadaptor minimizes the risk of exposure to hazardous drug substances, and eliminates the risk of needle stick injuries. The drug mixing system is intended for use with a luer fitted syringe, and is particularly useful for handling toxic drugs such as antineoplastic drugs.
The Tevadaptor drug mixing system includes a receptacle port adapter that can be inserted into a port of a fluid receptacle, such as an IV bag. A vial adapter element is provided for connection to a vial containing a drug. A syringe adapter element may be attached to a syringe and to the receptacle port adapter and/or the vial adapter element. The receptacle port adapter, syringe adapter element and/or the vial adapter element may be vented to the atmosphere in a manner that prevents release to the atmosphere of possibly harmful contents of the vial in a liquid, solid or gaseous form.
The syringe adapter element may have a needle that fluidly communicates with the contents of the syringe. The needle does not normally protrude outwards, but rather is sealed inside the syringe adapter element by a septum. The syringe adapter element may be screwed onto the luer lock tip of the syringe. The needle of the syringe adapter element is now in fluid communication with the contents of the syringe.
Similarly, the vial adapter element may have a spike that fluidly communicates with the contents of the vial, and is sealed by a septum. The vial may be pushed onto the vial adapter element, wherein the spike of the vial adapter element punctures the septum of the vial. The vial adapter element may then be pushed onto the syringe adapter element, wherein the needle of the syringe adapter element punctures the septa of the syringe adapter element and the vial adapter assembly. This allows fluid to flow from the syringe through the needle of the syringe adapter element and through the spike of the vial adapter element to the vial.
After filling the vial with a desired amount of fluid, the vial adapter assembly may be separated from the syringe adapter element. During separation, the needle of the syringe adapter element is sealed by elastomeric septa. In this manner, no fluid drips outwards.
The present invention seeks to provide further features to a drug mixing system, particularly a vial adapter with improved connection features for connecting thereto a vial, as is described further in detail hereinbelow.
There is thus provided in accordance with an embodiment of the present invention a vial adapter element for use in a drug mixing system including a body, a vial connection port extending from the body, a hollow vial puncturing spike (optionally mounted in a counterbore formed in the body) that protrudes into the vial connection port and is in fluid communication with a syringe-adapter-element connection port that extends from the body, and a plurality of resilient tongues spaced around an inner wall of the body, the tongues being located in gaps formed in the inner wall of the body (e.g., each tongue optionally including a cantilevered arm that terminates in a chamfered lug). A biasing device may be optionally placed in the counterbore for creating a biasing force towards the resilient tongues.
In accordance with an embodiment of the present invention the body includes an outwardly extending proximal rim. The cantilevered arms may extend along the inner wall of the body. The cantilevered arms may be as thick as the inner wall of body, and the chamfered lugs may be thicker than the cantilevered arms.
In accordance with an embodiment of the present invention each chamfered lug extends radially towards a center of the body and is located at a proximal end of a cutout formed in the body.
In accordance with an embodiment of the present invention the biasing device includes a coil spring. Alternatively, in accordance with another embodiment of the present invention the biasing device includes a flexible cylindrical element having a hole for the spike to pass therethrough.
In accordance with another embodiment of the present invention the body includes a conical flange that extends inwards from the rim. Each cantilevered arm may depend from a proximal end of a cutout formed in the conical flange, and an appendage may extend from a distal edge of the cantilevered arm from which extends the chamfered lug.
In accordance with another embodiment of the present invention each cantilevered arm may extend from a floor of the body and may be located in a cutout formed in the body, and an appendage may extend from a distal edge of the cantilevered arm from which extends the chamfered lug.
The present invention will be understood and appreciated more fully from the following detailed description, taken in conjunction with the drawings in which:
Reference is now made to
Vial adapter element 10 may include a vial connection port 12, described in detail below. A hollow vial puncturing spike 14 protrudes into the middle of vial connection port 12. Spike 14 sits in a counterbore 28, which can be integrally molded as part of body 17, for example.
Spike 14 is in fluid communication with syringe-adapter-element connection port 16. As is known in the art, such as in PCT patent application WO 2005/041846, syringe-adapter-element connection port 16 includes a hollow tubular portion (not shown) in fluid communication with spike 14. The tubular portion is covered at an end opposite to spike 14 with a septum (not shown). A syringe adapter element (not shown) has a needle and can be pushed on to syringe-adapter-element connection port 16, whereupon the needle of the syringe adapter element punctures the septum of the tubular portion of port 16, This effects fluid communication between the syringe adapter element and spike 14 so that contents (e.g., a drug in liquid solution) of a syringe (not shown) connected to the syringe adapter element can flow to spike 14 and from there into a vial (not shown) that has previously been connected to vial connection port 12.
In the embodiment illustrated in
When a vial is pushed into vial connection port 12, the neck of the vial initially contacts the chamfered lug 24 and pushes them radially outwards as the neck of the vial pushes past them. The chamfered lugs 24 can be more resilient, less resilient or just as resilient in the radially outward direction (perpendicular to spike 14) compared with the axial direction (parallel to spike 14), by appropriately designing the moment of inertia of cantilevered arm 22 to be either greater, smaller or equal in the radially outward direction compared with the axial direction, respectively
After pushing the vial into vial connection port 12, spike 14 punctures a septum of the vial and the vial head goes into the inner diameter of the wall of body 17. In order to compensate for any mismatch in tolerances when connecting the vial to port 12, a biasing device 30 is placed in counterbore 28. Biasing device 30 urges the vial against chamfered lugs 24 of tongues 20, thereby ensuring minimal residual volume when the contents are emptied from the vial. In the embodiment illustrated in
Reference is now made to
Reference is now made to
Reference is now made to
It is appreciated that various features of the invention which are, for clarity, described in the contexts of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.
Number | Name | Date | Kind |
---|---|---|---|
4128098 | Bloom et al. | Dec 1978 | A |
4675020 | McPhee | Jun 1987 | A |
4759756 | Forman et al. | Jul 1988 | A |
5122123 | Vaillancourt | Jun 1992 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5279576 | Loo et al. | Jan 1994 | A |
5304163 | Bonnici et al. | Apr 1994 | A |
5344417 | Wadsworth, Jr. | Sep 1994 | A |
5641010 | Maier | Jun 1997 | A |
5647845 | Haber et al. | Jul 1997 | A |
5890610 | Jansen et al. | Apr 1999 | A |
5989237 | Fowles et al. | Nov 1999 | A |
6019750 | Fowles et al. | Feb 2000 | A |
6022339 | Fowles et al. | Feb 2000 | A |
D472316 | Douglas et al. | Mar 2003 | S |
6558365 | Zinger et al. | May 2003 | B2 |
6685692 | Fathallah | Feb 2004 | B2 |
6715520 | Andreasson et al. | Apr 2004 | B2 |
6875205 | Leinsing | Apr 2005 | B2 |
7452348 | Hasegawa | Nov 2008 | B2 |
7648491 | Rogers | Jan 2010 | B2 |
D616984 | Gilboa | Jun 2010 | S |
20020127150 | Sasso | Sep 2002 | A1 |
20020128628 | Fathallah | Sep 2002 | A1 |
20030153895 | Leinsing | Aug 2003 | A1 |
20050148994 | Leinsing | Jul 2005 | A1 |
20070106244 | Mosler et al. | May 2007 | A1 |
20080177244 | Capitaine et al. | Jul 2008 | A1 |
20090177177 | Zinger et al. | Jul 2009 | A1 |
20090177178 | Pedersen | Jul 2009 | A1 |
Number | Date | Country |
---|---|---|
WO9105581 | May 1991 | WO |
Number | Date | Country | |
---|---|---|---|
20100179506 A1 | Jul 2010 | US |